FDA panel gives thumbs up to Moderna s COVID vaccine, paving way for final approval | National newsminer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsminer.com Daily Mail and Mail on Sunday newspapers.
US panel recommends emergency approval of COVID-19 vaccine Moderna
Epidemiologist Arnold Monto said that nothing should be read into the fact that the vote was even more overwhelming than last week s in favor of the Pfizer vaccine.
Share Via Email
| A+A A-
A syringe and a bottle reading Vaccine Covid-19 next to the Moderna biotech company logo. (File photo| AFP) By AFP
WASHIGNTON: A US panel of experts on Thursday voted to recommend emergency approval of Moderna s COVID-19 vaccine, paving the way for six million doses to start shipping as soon as this weekend.
The Food and Drug Administration is now expected to imminently grant an emergency use authorization (EUA), which would make Moderna s vaccine the second to be approved in a Western country.
2nd Covid vaccine: FDA panel gives thumbs up to Moderna, paving way for final approval
Updated Dec 18, 2020;
Posted Dec 18, 2020
A University of Miami Miller School of Medicine phlebotomist prepares to take a blood sample from a participant in a Moderna COVID-19 vaccine trial.AP
Facebook Share
Chris Sommerfeldt New York Daily News (TNS)
An influential government panel of scientists unanimously endorsed Moderna’s coronavirus vaccine candidate for emergency use on Thursday, paving the way for final approval from U.S. regulators as early as this week.
The Vaccines and Related Biological Products Advisory Committee, which advises the Food and Drug Administration on drug and inoculation approvals, voted 20-0 that the FDA should give the green light for the Moderna vaccine to be administered to those 18 years and older. One member of the committee abstained from the vote.
GlaxoSmithKline And Vir Biotechnology Kick Off ACTIV-3 Covid Trial
Thu, 17th Dec 2020 21:45
(Alliance News) - GlaxoSmithKline PLC and Vir Biotechnology Inc said Thursday they have started the US National Institutes of Health sponsored ACTIV-3 trial for evaluating VIR-7831 in hospitalised adults with Covid-19.
The pair said that the first patient has been dosed in a new sub-trial of the NIH s Accelerating Covid-19 Therapeutic Interventions & Vaccines Program Phase 3 clinical trial. This trial is designed to evaluate the safety and efficacy of VIR-7831 for the treatment of hospitalised adults with COVID-19.
VIR-7831, also known as GSK4182136, is a fully human anti-SARS-CoV-2 investigational monoclonal antibody to treat the virus.
ISSAM AHMED, AFP
17 DECEMBER 2020
A US panel of experts on Thursday voted to recommend emergency approval of Moderna s Covid-19 vaccine, paving the way for six million doses to start shipping as soon as this weekend.
The Food and Drug Administration is now expected to imminently grant an emergency use authorization (EUA), which would make Moderna s vaccine the second to be approved in a Western country.
The panel voted 20 in favor, none against, with one abstention.
They had been asked to answer the question: Based on the totality of scientific evidence available, do the benefits of the Moderna COVID-19 Vaccine outweigh its risks for use in individuals 18 years of age and older?